Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Van Cutsem

Showing results (111-120 of 499) with videos related to

Pageof 50
Sort By:
Endoscopy|July 22, 2017
A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice: the IGNITE-1 studyWim Laleman, Schalk van der Merwe, Len Verbeke, et al.
Cancers|September 3, 2016
Imaging in Colorectal Cancer: Progress and Challenges for the CliniciansEric Van Cutsem, Henk M W Verheul, Patrik Flamen, et al.
Human Mutation|January 12, 2005
Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposis (FAP): a Belgian studyGeneviève Michils, Sabine Tejpar, Reinhilde Thoelen, et al.
European Radiology|May 25, 2010
Percutaneous isolated liver perfusion with occlusion balloons and a catheter-based stent-graft-like perfusion device: an experimental study in a porcine modelGeert Maleux, Diethard Monbaliu, Chris Verslype, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Disease course patterns after discontinuation of bevacizumab: pooled analysis of randomized phase III trialsDavid Miles, Nadia Harbeck, Bernard Escudier, et al.
Cancer Treatment Reviews|March 17, 2023
European expert panel consensus on the clinical management of BRAF<sup>V600E</sup>-mutant metastatic colorectal cancerErika Martinelli, Dirk Arnold, Andres Cervantes, et al.
Acta Oncologica (Stockholm, Sweden)|July 1, 2010
The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancerMaarten Lambrecht, Christophe Deroose, Sarah Roels, et al.
JAMA Oncology|October 11, 2016
Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 TrialsSabine Tejpar, Sebastian Stintzing, Fortunato Ciardiello, et al.
ESMO Open|July 30, 2019
Educational needs in gastrointestinal cancer: a consensus position paper from the ESMO Gastrointestinal Cancer FacultyFlorian Lordick, Radka Obermannova, Doris Vola, et al.
Future Oncology (London, England)|February 11, 2021
Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study designJosep Tabernero, Julien Taieb, Gerald W Prager, et al.
Pageof 50

Showing results (111-120 of 499) with videos related to

Sort By:
Pageof 50
Endoscopy|July 22, 2017
A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice: the IGNITE-1 studyWim Laleman, Schalk van der Merwe, Len Verbeke, et al.
Cancers|September 3, 2016
Imaging in Colorectal Cancer: Progress and Challenges for the CliniciansEric Van Cutsem, Henk M W Verheul, Patrik Flamen, et al.
Human Mutation|January 12, 2005
Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposis (FAP): a Belgian studyGeneviève Michils, Sabine Tejpar, Reinhilde Thoelen, et al.
European Radiology|May 25, 2010
Percutaneous isolated liver perfusion with occlusion balloons and a catheter-based stent-graft-like perfusion device: an experimental study in a porcine modelGeert Maleux, Diethard Monbaliu, Chris Verslype, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Disease course patterns after discontinuation of bevacizumab: pooled analysis of randomized phase III trialsDavid Miles, Nadia Harbeck, Bernard Escudier, et al.
Cancer Treatment Reviews|March 17, 2023
European expert panel consensus on the clinical management of BRAF<sup>V600E</sup>-mutant metastatic colorectal cancerErika Martinelli, Dirk Arnold, Andres Cervantes, et al.
Acta Oncologica (Stockholm, Sweden)|July 1, 2010
The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancerMaarten Lambrecht, Christophe Deroose, Sarah Roels, et al.
JAMA Oncology|October 11, 2016
Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 TrialsSabine Tejpar, Sebastian Stintzing, Fortunato Ciardiello, et al.
ESMO Open|July 30, 2019
Educational needs in gastrointestinal cancer: a consensus position paper from the ESMO Gastrointestinal Cancer FacultyFlorian Lordick, Radka Obermannova, Doris Vola, et al.
Future Oncology (London, England)|February 11, 2021
Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study designJosep Tabernero, Julien Taieb, Gerald W Prager, et al.
Pageof 50